Constantino Michael T.'s Form 4/A amendment
Amended9 Meters Biopharma, Inc. (NMTR) · filed Mar 21, 2022
- Accession no.
- 0001551986-22-000025
- Filed
- Mar 21, 2022
- Trade date
- Aug 20, 2020
- Filing delay
- 578 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 21, 2020
This filing lists 1 non-derivative transaction. Open-market purchases total $19.9K. It was filed 578 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Constantino Michael T.CIK 0001817285 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2020 | Common stock | PPurchaseAcquired | +26,508.74 | $0.75F1 | +$19,881.56 | 26,508.74 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.7501 to $0.76, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Referenced by the price of 1 transaction in Table I.
Remarks
This amendment on Form 4/A is being filed with the Securities and Exchange Commission to amend the Form 4, originally filed by the reporting person on August 21, 2020 (the "Original Form 4"), which inadvertently overstated the amount of shares purchased and the amount of securities owned following the reported transaction. This correction also effects (and is deemed to also correct and amend to the extent necessary) the total number of shares owned directly by reporting person reported in subsequent Forms 4. This amendment also corrects the weighted-average price per share reported in the Original Form 4. As of the date of filing this Form 4/A, the reporting person directly owns 44,508.74 shares of common stock. EX-24: Power of Attorney